Your browser doesn't support javascript.
loading
High throughput mutagenesis for identification of residues regulating human prostacyclin (hIP) receptor expression and function.
Bill, Anke; Rosethorne, Elizabeth M; Kent, Toby C; Fawcett, Lindsay; Burchell, Lynn; van Diepen, Michiel T; Marelli, Anthony; Batalov, Sergey; Miraglia, Loren; Orth, Anthony P; Renaud, Nicole A; Charlton, Steven J; Gosling, Martin; Gaither, L Alex; Groot-Kormelink, Paul J.
Afiliação
  • Bill A; Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America.
  • Rosethorne EM; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom.
  • Kent TC; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom.
  • Fawcett L; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom.
  • Burchell L; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom.
  • van Diepen MT; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom.
  • Marelli A; Infectious Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • Batalov S; Infectious Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • Miraglia L; Infectious Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • Orth AP; Infectious Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
  • Renaud NA; Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America.
  • Charlton SJ; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom.
  • Gosling M; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom.
  • Gaither LA; Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America.
  • Groot-Kormelink PJ; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom; Musculoskeletal Disease Area, Novartis Institutes for Biomedical Research, Basel, Switzerland.
PLoS One ; 9(6): e97973, 2014.
Article em En | MEDLINE | ID: mdl-24886841
ABSTRACT
The human prostacyclin receptor (hIP receptor) is a seven-transmembrane G protein-coupled receptor (GPCR) that plays a critical role in vascular smooth muscle relaxation and platelet aggregation. hIP receptor dysfunction has been implicated in numerous cardiovascular abnormalities, including myocardial infarction, hypertension, thrombosis and atherosclerosis. Genomic sequencing has discovered several genetic variations in the PTGIR gene coding for hIP receptor, however, its structure-function relationship has not been sufficiently explored. Here we set out to investigate the applicability of high throughput random mutagenesis to study the structure-function relationship of hIP receptor. While chemical mutagenesis was not suitable to generate a mutagenesis library with sufficient coverage, our data demonstrate error-prone PCR (epPCR) mediated mutagenesis as a valuable method for the unbiased screening of residues regulating hIP receptor function and expression. Here we describe the generation and functional characterization of an epPCR derived mutagenesis library compromising >4000 mutants of the hIP receptor. We introduce next generation sequencing as a useful tool to validate the quality of mutagenesis libraries by providing information about the coverage, mutation rate and mutational bias. We identified 18 mutants of the hIP receptor that were expressed at the cell surface, but demonstrated impaired receptor function. A total of 38 non-synonymous mutations were identified within the coding region of the hIP receptor, mapping to 36 distinct residues, including several mutations previously reported to affect the signaling of the hIP receptor. Thus, our data demonstrates epPCR mediated random mutagenesis as a valuable and practical method to study the structure-function relationship of GPCRs.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Prostaglandina / Mutagênese / Sequenciamento de Nucleotídeos em Larga Escala / Aminoácidos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Prostaglandina / Mutagênese / Sequenciamento de Nucleotídeos em Larga Escala / Aminoácidos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos